Evidence map›Paper›PMID 28811708›Full record

ArticleWorld journal of gastroenterology2017

Involvement of CRF2 signaling in enterocyte differentiation.

Benjamin Ducarouge, Marjolaine Pelissier-Rota, Rebecca Powell, Alain Buisson, Bruno Bonaz, Muriel Jacquier-Sarlin

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. An initial genome-wide investigation of protein-losing enteropathy in Gordon setters: Exploratory observations.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2021
    Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Benjamin DucarougeBenjamin Ducarouge, Equipe de l'apoptose, du cancer et du développement, Centre Léon Bérard, F-69008 Lyon, France.
Marjolaine Pelissier-RotaBenjamin Ducarouge, Equipe de l'apoptose, du cancer et du développement, Centre Léon Bérard, F-69008 Lyon, France.
Rebecca PowellBenjamin Ducarouge, Equipe de l'apoptose, du cancer et du développement, Centre Léon Bérard, F-69008 Lyon, France.
Alain BuissonBenjamin Ducarouge, Equipe de l'apoptose, du cancer et du développement, Centre Léon Bérard, F-69008 Lyon, France.
Bruno BonazBenjamin Ducarouge, Equipe de l'apoptose, du cancer et du développement, Centre Léon Bérard, F-69008 Lyon, France.
Muriel Jacquier-SarlinBenjamin Ducarouge, Equipe de l'apoptose, du cancer et du développement, Centre Léon Bérard, F-69008 Lyon, France.
Laboratoire de Psychologie et NeuroCognition · FRUniversité Grenoble Alpes · FRCentre Hospitalier Universitaire de Grenoble · FRGrenoble Institute of Neurosciences · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the role of corticotropin releasing factor receptor (CRF2) in epithelial permeability and enterocyte cell differentiation.

methodsFor this purpose, we used rat Sprague Dawley and various colon carcinoma cell lines (SW620, HCT8R, HT-29 and Caco-2 cell lines). Expression of CRF2 protein was analyzed by fluorescent immunolabeling in normal rat colon and then by western blot in dissociated colonic epithelial cells and in the lysates of colon carcinoma cell lines or during the early differentiation of HT-29 cells (ten first days). To assess the impact of CRF2 signaling on colonic cell differentiation, HT-29 and Caco-2 cells were exposed to Urocortin 3 recombinant proteins (Ucn3, 100 nmol/L). In some experiments, cells were pre-exposed to the astressin 2b (A2b) a CRF2 antagonist in order to inhibit the action of Ucn3. Intestinal cell differentiation was first analyzed by functional assays: the trans-cellular permeability and the para-cellular permeability were determined by Dextran-FITC intake and measure of the transepithelial electrical resistance respectively. Morphological modifications associated to epithelial dysfunction were analyzed by confocal microscopy after fluorescent labeling of actin (phaloidin-TRITC) and intercellular adhesion proteins such as E-cadherin, p120ctn, occludin and ZO-1. The establishment of mature adherens junctions (AJ) was monitored by following the distribution of AJ proteins in lipid raft fractions, after separation of cell lysates on sucrose gradients. Finally, the mRNA and the protein expression levels of characteristic markers of intestinal epithelial cell (IEC) differentiation such as the transcriptional factor krüppel-like factor 4 (KLF4) or the dipeptidyl peptidase IV (DPPIV) were performed by RT-PCR and western blot respectively. The specific activities of DPPIV and alkaline phosphatase (AP) enzymes were determined by a colorimetric method.

resultsCRF2 protein is preferentially expressed in undifferentiated epithelial cells from the crypts of colon and in human colon carcinoma cell lines. Furthermore, CRF2 expression is down regulated according to the kinetic of HT-29 cell differentiation. By performing functional assays, we found that Ucn3-induced CRF2 signaling alters both para- and trans-cellular permeability of differentiated HT-29 and Caco-2 cells. These effects are partly mediated by Ucn3-induced morphological changes associated with the disruption of mature AJ in HT-29 cells and tight junctions (TJ) in Caco-2 cells. Ucn3-mediated activation of CRF2 decreases mRNA and protein expression levels of KLF4 a transcription factor involved in IEC differentiation. This signaling is correlated to a down-regulation of key IEC markers such as DPPIV and AP, at both transcriptional and post-transcriptional levels.

conclusionOur findings suggest that CRF2 signaling could modulate IEC differentiation. These mechanisms could be relevant to the stress induced epithelial alterations found in inflammatory bowel diseases.

Indexed as

Cell DifferentiationAdherens JunctionsAnimalsBiomarkersCell Line, TumorColonCorticotropin-Releasing HormoneDipeptidyl Peptidase 4Down-RegulationEnterocytesHumansInflammatory Bowel DiseasesIntestinal MucosaKruppel-Like Factor 4Kruppel-Like Transcription FactorsMaleastressin-2BBiomarkersCorticotropin-Releasing HormoneCRF receptor type 2Dipeptidyl Peptidase 4DPP4 protein, ratKLF4 protein, humanKlf4 protein, ratKruppel-Like Factor 4Kruppel-Like Transcription FactorsPeptide FragmentsPeptides, CyclicReceptors, Corticotropin-Releasing HormoneRecombinant Proteinsurocortin 3, ratUrocortinsCell permeabilityColon carcinoma cell linesCorticotrophin releasing factor 2Epithelial cell differentiationIntercellular adhesion complexesUrocortin3

Identifiers

PMID28811708
PMCPMC5537180
OpenAlexW2742162959

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.